Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
about
Elevated intracellular calcium triggers recruitment of the receptor cross-talk accessory protein calcyon to the plasma membraneHeteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapesHeterodimerization of opioid receptor-like 1 and mu-opioid receptors impairs the potency of micro receptor agonistFunctional characterization of G-protein-coupled receptors: a bioinformatics approach.G protein-coupled receptor heterocomplexes in neuropsychiatric disorders.Tetraspanin 3c requirement for pigment cell interactions and boundary formation in zebrafish adult pigment stripes.Third-party bioluminescence resonance energy transfer indicates constitutive association of membrane proteins: application to class a g-protein-coupled receptors and g-proteins.Pharmacogenetics of antidepressant response.Design strategies for bivalent ligands targeting GPCRs.Oligomerisation of C. elegans olfactory receptors, ODR-10 and STR-112, in yeast.Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors.Muscarinic acetylcholine receptor M3 modulates odorant receptor activity via inhibition of β-arrestin-2 recruitment.Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function.Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomersRoles of G-protein-coupled receptor dimerization.Protein-protein interactions at the adrenergic receptors.Regulation of alpha2AR trafficking and signaling by interacting proteins.N-linked glycosylation of protease-activated receptor-1 at extracellular loop 2 regulates G-protein signaling biasMechanisms of propranolol action in infantile hemangiomaCross-desensitization and cointernalization of H1 and H2 histamine receptors reveal new insights into histamine signal integration.Postischemic brain injury is attenuated in mice lacking the beta2-adrenergic receptor.New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle.Using linkage analysis to identify quantitative trait loci for sleep apnea in relationship to body mass index.Cross-talk from β-adrenergic receptors modulates α2A-adrenergic receptor endocytosis in sympathetic neurons via protein kinase A and spinophilin.Cell-surface targeting of alpha2-adrenergic receptors -- inhibition by a transport deficient mutant through dimerizationHeterodimerisation of G protein-coupled receptors: implications for drug design and ligand screening.Heterodimerization of β2 adrenergic receptor and somatostatin receptor 5: Implications in modulation of signaling pathway.Determination of the minimal functional ligand-binding domain of the GABAB1b receptor.Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway.Adrenergic receptor genotypes influence postoperative outcomes in infants in the Single-Ventricle Reconstruction Trial.Suppression of heregulin β signaling by the single N-glycan deletion mutant of soluble ErbB3 protein.The P2Y₄ receptor forms homo-oligomeric complexes in several CNS and PNS neuronal cells.The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition.β1-adrenergic receptor O-glycosylation regulates N-terminal cleavage and signaling responses in cardiomyocytes.N-glycosylation and disulfide bonding affects GPRC6A receptor expression, function, and dimerization.Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling.Heterodimerization and surface localization of G protein coupled receptorsModulation of Ca2+ channels by heterologously expressed wild-type and mutant human micro-opioid receptors (hMORs) containing the A118G single-nucleotide polymorphism.Ligand-independent CXCR2 dimerization.
P2860
Q24297398-D714632C-7436-4D2D-A96A-6156CCC5CA04Q24630645-5655785E-C2F0-41CA-AB56-183A7EACB5ACQ24633877-76EAC128-FB8F-4661-AECF-D83071668436Q28574073-875AB538-2589-4475-8C7E-B6283512B087Q30009384-47D3BD89-C49B-43DD-A91F-4BE078FFE220Q30385233-9C38584F-4DEC-416F-85BF-3784EF662D6CQ30576210-791D5951-5D3A-4072-BAF7-12470A488972Q33858582-A58B2FB6-473D-4544-8616-26518259D1ACQ34155796-6516F7A8-C2E5-49B7-8979-4D93007A26CCQ34180510-2F1C16FF-4A79-402C-BC78-753031A77500Q34257384-7199CE4C-9AAE-43B4-A5C1-61D53FF029E8Q34291539-BCBCB654-0E51-4ECC-A3D7-8F633A1480D2Q35214958-64FDBC0E-9908-442A-83B2-A148F6306EE7Q35279688-1A94CD6E-95CB-450A-8D86-63B96F676125Q35594835-60AF6C7C-8E14-42CD-8883-8291AB3B86E9Q35622424-19EFCF8C-0090-4AA6-A724-5CE761D2EA52Q35791490-15B601FA-70F3-4FC6-A89B-8F9C71876D74Q35828056-C7B1B9FF-E0EA-4143-87BD-4CCBC039C9A3Q35845790-3A3112D0-0305-45C4-B52D-2B80CCDC5387Q36085996-CFC98252-71FD-469C-84C7-AD5BB5F89FC0Q36776746-77AC59AD-6199-4F14-A05E-605109EAF0C3Q36867076-D5BF7D5B-939A-41F8-87D9-650263A2F855Q37050877-3B702D7B-DC11-44B2-B121-66BB5C2BF13FQ37181834-36F60B90-F4EE-4FA3-9074-0F43CC7C5DECQ37213951-AD2D37EF-55EE-4F79-8ED9-F14CD78770C8Q37281603-9B5DE9E3-EFF8-4546-947C-4C4169415D75Q38028547-EDCA4FDF-40E8-4621-A5BC-C0CC7168650EQ38304895-12C140BE-AE30-4BE7-8235-2FCB05463769Q38335448-F7448346-E3D8-4345-856D-8B63313AC702Q38345800-723CA38E-04CF-4590-A592-B331191E19AFQ38653332-C23C0E69-7002-4AD0-87EF-953D4169EBBCQ39085589-52FD0E24-D52F-49F6-B324-83A7683FBE94Q40726653-1FA3555B-1BA8-445F-B6CC-B9630D51A3A6Q41268689-7654ECD8-66D4-4D49-A03B-E6EAC145C9EAQ41367007-AB4E6136-A681-4275-BCA4-E52C12165111Q41532436-060D982B-00C4-4B0A-AC14-2332BE920D50Q41881332-D2996082-EAE5-485B-9D9A-1274FB96EEF6Q41900573-5AEBD8D6-C09C-45E2-8B7B-28F21C747531Q44333078-4116E5B2-85BB-4D77-90A7-0855D8B4CB5AQ44530891-5F491B87-15B2-4848-947E-D491926E3B87
P2860
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
@ast
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
@en
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
@en-gb
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
@nl
type
label
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
@ast
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
@en
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
@en-gb
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
@nl
prefLabel
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
@ast
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
@en
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
@en-gb
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
@nl
P2093
P2860
P921
P3181
P356
P1476
Heterodimerization of alpha 2A- and beta 1-adrenergic receptors
@en
P2093
Amanda M Castleberry
Anthony G Lau
Jianguo Xu
Randy A Hall
Srividya Balasubramanian
P2860
P304
P3181
P356
10.1074/JBC.M207968200
P407
P577
2003-03-21T00:00:00Z